Edesa Biotech, Inc. (EDSA)
↓ Download CSV- Sector Manufacturing
- Incorporated A1
- Fiscal year ends Sep 30
Key ratios (FY2025)
-57.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $328.8K | — | $0 | $228.3K | $1.27M |
| Cost of Revenue | — | — | — | — | $0 | $17.6K | — | $0 | — | — |
| Operating Income | -$7.91M | -$7.01M | -$9.22M | -$18.37M | -$23.68M | -$6.40M | — | -$1.62M | -$5.22M | -$4.91M |
| Net Income | -$7.19M | -$6.17M | -$8.37M | -$17.55M | -$13.34M | -$6.36M | — | -$1.54M | -$5.03M | -$5.03M |
| EPS (Diluted) | $-1.27 | $-1.93 | $-2.93 | — | — | — | — | — | — | $-0.57 |
| Total Assets | $13.53M | $3.81M | $8.89M | $11.58M | $14.58M | $10.76M | $5.72M | $3.40M | $7.72M | $12.94M |
| Total Liabilities | — | $1.83M | $1.84M | $2.18M | $1.53M | $1.65M | $461.6K | — | — | — |
| Shareholders' Equity | $12.45M | $1.98M | $7.05M | $9.39M | $13.06M | $6.63M | $5.26M | $3.21M | $5.00M | $12.31M |
| Cash & Equivalents | $10.80M | $1.00M | $5.40M | $7.09M | $7.84M | $7.21M | $5.03M | $3.37M | $5.00M | $7.42M |
| Operating Cash Flow | -$7.32M | -$4.89M | -$6.64M | -$12.28M | -$13.66M | -$4.99M | — | -$1.29M | -$4.70M | -$4.51M |
| Capital Expenditures | — | — | $0 | $5.7K | $6.1K | $4.9K | — | $6.9K | $302.7K | $402.3K |
| Shares Outstanding | 7.14M | 3.25M | 3.08M | 2.38M | 13.30M | 9.62M | 7.50M | 3.24M | 1.50M | 10.14M |